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METHODOLOGY
Subcellular fractionation method 
to study endosomal trafficking of Kaposi’s 
sarcoma-associated herpesvirus
Lia R. Walker, Hosni A. M. Hussein and Shaw M. Akula*
Abstract 
Background: Virus entry involves multiple steps and is a highly orchestrated process on which successful infection 
collectively depends. Entry processes are commonly analyzed by monitoring internalized virus particles via Western 
blotting, polymerase chain reaction, and imaging techniques that allow scientist to track the intracellular location of 
the pathogen. Such studies have provided abundant direct evidence on how viruses interact with receptor mol-
ecules on the cell surface, induce cell signaling at the point of initial contact with the cell to facilitate internalization, 
and exploit existing endocytic mechanisms of the cell for their ultimate infectious agenda. However, there is dearth 
of knowledge in regards to trafficking of a virus via endosomes. Herein, we describe an optimized laboratory proce-
dure to isolate individual organelles during different stages of endocytosis by performing subcellular fractionation. 
This methodology is established using Kaposi’s sarcoma-associated herpesvirus (KSHV) infection of human foreskin 
fibroblast (HFF) cells as a model. With KSHV and other herpesviruses alike, envelope glycoproteins have been widely 
reported to physically engage target cell surface receptors, such as integrins, in interactions leading to entry and 
subsequent infection.
Results: Subcellular fractionation was used to isolate early and late endosomes (EEs and LEs) by performing a series 
of centrifugations steps. Specifically, a centrifugation step post-homogenization was utilized to obtain the post-
nuclear supernatant containing intact intracellular organelles in suspension. Successive fractionation via sucrose 
density gradient centrifugation was performed to isolate specific organelles including EEs and LEs. Intracellular KSHV 
trafficking was directly traced in the isolated endosomal fractions. Additionally, the subcellular fractionation approach 
demonstrates a key role for integrins in the endosomal trafficking of KSHV. The results obtained from fractionation 
studies corroborated those obtained by traditional imaging studies.
Conclusions: This study is the first of its kind to employ a sucrose flotation gradient assay to map intracellular KSHV 
trafficking in HFF cells. We are confident that such an approach will serve as a powerful tool to directly study intracel-
lular trafficking of a virus, signaling events occurring on endosomal membranes, and dynamics of molecular events 
within endosomes that are crucial for uncoating and virus escape into the cytosol.
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Background
As pathogenic hijackers of cellular machinery, viruses 
enter target cells via diverse, complex, and still fairly enig-
matic processes that are presumed to be cell type depend-
ent. It is widely accepted that viruses access a target cell’s 
interior via interactions between viral envelope glycopro-
teins and host cell surface receptors. Such glycoprotein: 
receptor interactions function in attachment and bind-
ing at the cell surface, successive internalization (uptake 
into the host cell), membrane fusion, and trafficking of 
the virus [1]. The virus entry process is generally studied 
by methods such as Western blotting, polymerase chain 
reaction (PCR), and imaging techniques using a selection 
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of both permissive and non-permissive cells. Such studies 
have enlightened us as it pertains to the mechanism by 
which different viruses interact with receptor molecules 
on the surface of cells and get internalized in an effort 
to set up a successful infection. Several viruses, includ-
ing herpesviruses utilize different modes of endocytosis 
to enter cells. Over the years, we have gathered scores of 
literature on how viruses enter cells by endocytosis pri-
marily via the use of inhibitors of these specific pathways. 
However, there is dearth of knowledge as to exactly how 
viruses utilizing the endocytic route are trafficked within 
the endosomes.
Opposed to the conventional methods frequently used 
to assess the intracellular location of virus particles, sub-
cellular fractionation is an advantageous approach allow-
ing specific isolation of intact early and late endosomes. 
Thus, a subcellular fractionation protocol was established 
in our laboratory to directly study the transit of virus 
within the endosomes in human foreskin fibroblast (HFF) 
cells. Kaposi’s sarcoma-associated herpesvirus (KSHV), a 
gamma-2-herpesvirus otherwise known as human her-
pesvirus-8 (HHV-8), served as our model viral candidate 
during the standardization process, as KSHV has been 
demonstrated to enter HFF cells via clathrin mediated 
endocytosis; the most extensively studied and best char-
acterized mechanism of endocytosis [2, 3].
KSHV has an expansive cellular tropism both in  vivo 
and in  vitro, and can infect a plethora of different cell 
types [4] presumably due to its ability to bind ubiquitous 
molecules expressed on target cells such as heparan sul-
fate (HS) [5]. KSHV binding to HS is thought to bring the 
virus in closer proximity to target cells such that perhaps 
more meaningful interactions with other receptor mol-
ecules, such as integrins [6], can occur to promote the 
actual entry process [5]. In fact, KSHV sets precedence as 
the first herpesvirus shown to interact with adherent tar-
get cell integrins in a step initiating the entry process [7]. 
Integrins are heterodimeric cell adhesion receptors com-
posed of non-covalently associated α and β subunits [8]. 
To facilitate virus entry and infection, KSHV envelope 
associated glycoprotein B (gB) is shown to interact with 
integrins via its two distinct integrin recognition motifs: 
(1) RGD (Arg-Gly-Asp), the major integrin binding motif 
and minimal peptide region known to interact with sub-
sets of integrins [7, 9]; and (2) disintegrin-like domain 
(DLD), the lesser studied and highly conserved integrin 
recognition motif that binds integrins RGD-indepen-
dently [10–12]. A multitude of studies have implicated 
KSHV gB interactions with RGD-binding integrins, α3β1, 
αVβ3, and αVβ5, as valuable for infectious virus entry [7, 
13–15]. However, both RGD and non-RGD-binding inte-
grins are believed to aid equally in virus entry [16]. For 
instance, recent studies by us [10] identified KSHV gB 
interactions with cell surface expressed integrin α9β1, a 
DLD-binding integrin, crucial to promoting viral infec-
tion of cells [10]. Aside from integrins, other receptors 
shown to have a role in KSHV entry are ephrin receptor 
tyrosine kinase A2 (EphA2) [17], dendritic cell-specific 
intercellular adhesion molecule-3-grabbing non-integrin 
(DC-SIGN) [18], and human cystine/glutamate exchange 
transporter system x–c (xCT) [1]. After binding to recep-
tors (i.e. proteins, carbohydrates, or lipids), the vast 
majority of viruses utilize endocytic routes to enter target 
cells [19].
The majority of our current knowledge as it relates to 
virus entry has been extrapolated qualitatively by means 
of electron microscopy and other imaging techniques. 
Alternatively, here we sought to map KSHV trafficking 
via the endosomes using biochemical analysis. In the pro-
cess, our study defines a critical role for α9β1 integrin in 
the ability of KSHV to escape LEs of HFF cells.
Results
KSHV particles are trafficked beyond the early endosome 
for late endosomal escape
KSHV enters HFF cells via clathrin-mediated endocy-
tosis [20]. Typically, cargo internalized by this mecha-
nism of endocytosis is thought to be directed from early 
endosomes (EEs) to late endosomes (LEs) then lysosomes 
to undergo degradation or changes to conformation [21]. 
To begin with, untreated HFF cells grown to 80 % conflu-
ency were cooled (incubated at 30 min at 4 °C), incubated 
with DMEM alone (30 min at 37 °C), collected and lysed 
in homogenization buffer; after which, centrifugation was 
performed to derive the post-nuclear supernatant (PNS) 
containing intracellular organelles in suspension (Fig. 1). 
The PNS adjusted to a concentration of 25  % sucrose 
and 1 mM EDTA was then subjected to fractionation via 
sucrose density gradient centrifugation followed by frac-
tion collection (Fig. 1).
Collected gradient fractions 1–6 of untreated HFF cells 
were analyzed by SDS-PAGE and Western blotting for 
the distribution of organelle markers: Rab7 (LE marker), 
Rab5 and early endosome antigen 1 (EEA1; EE markers), 
and lysosome-associated membrane protein (LAMP1; LE 
and lysosome marker) [22, 23] (Fig.  2A). Fractions 1–3 
contained the LEs with the majority being concentrated 
in fraction 1 as detected by Rab7 and LAMP1 expres-
sion. Fractions 4–6 contained the EEs with the majority 
being concentrated in fraction 5 as detected by Rab5 and 
EEA1 expression (Fig. 2A). To exclude possible contami-
nation of the fractions with other cellular components, 
nuclear marker histone H3 [24] served as a negative con-
trol (Fig. 2A); gradient fractions are void of nuclei which 
are totally removed during the post-homogenization cen-
trifugation step [25]. Notably, comparatively assessing 
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the density profile of collected gradient fractions 1–6 
from both uninfected and KSHV infected HFF cells by 
refractometric analysis revealed that KSHV infection of 
HFF cells did not alter floating density of the endosome 
containing gradient fractions (data not shown), nor did 
KSHV infection of HFF cells seem to alter fraction distri-
bution of early and late endosomes (Fig. 2A). LEs (some-
times referred to as pre-lysosomes [26], lysosomes, and 
Fig. 1 Schematic representation of the sucrose flotation assay for endosome purification. This study used uninfected and KSHV (MOI of 5 DNA cop-
ies/cell) infected HFF cells




Fig. 2 Detection of KSHV in endosomal fractions. A Distribution of endosomal membranes was determined from uninfected and KSHV infected 
HFF cells using sucrose gradient fractions. Equal-volume aliquots from each gradient fraction were separated by SDS-PAGE and probed by Western 
blotting against organelle markers: Rab5 and EEA1 (EE markers), Rab7 (LE marker), LAMP1 (LE and lysosome marker), and histone H3 (nuclear 
marker). B Lysosome detection in sucrose gradient fractions of uninfected and KSHV infected HFF cells. Acid phosphatase activity was analyzed by 
using Acid Phosphatase Assay Kit (Sigma). C KSHV escapes from the LE. Following gradient centrifugation, viral genomic DNA was extracted from 
each recovered fraction. Fractions were then quantified for the content of internalized viral DNA by performing qPCR using specific primers. Data 
(panels B, C) represent the average ±SD (error bars) of three experiments. Columns with different alphabets indicate statistical significance (p < 0.05) 
by least significant difference (LSD)
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the endolysosome hybrid organelle—from where mature 
lysosomes bud—are said to be difficult to distinguish 
[27], as basic sucrose gradient centrifugation procedures 
are shown to forgo total separation of such organelles 
[28]. Here, acid phosphatase (an established enzyme 
marker for identifying lysosomes in subcellular fractions; 
[29]) activity was analyzed to detect the level of lyso-
some enrichment in collected gradient fractions (Fig. 2B). 
Upon fraction comparison, acid phosphatase activity in 
both the uninfected and KSHV infected HFF cells was 
detected in fractions 1–3 with fraction 1 displaying the 
highest phosphatase activity. Activity of acid phosphatase 
foreseeably coincided with the LE fractions (fractions 
1–3; Fig.  2A); although acid hydrolases (e.g. acid phos-
phatase) majorly localize in lysosomes, these enzymes 
can be found in LEs as well [27]. Therefore, such findings 
provide even further evidence for the presence of LEs in 
the said fractions.
Having established the fractions that contain early 
and late endosomes, we purified endosomes via a 
sucrose flotation gradient to quantitatively track KSHV 
in infected HFF cells post-internalization and to char-
acterize possible role(s) for DLD-binding integrins dur-
ing this stage of the entry process via qPCR (Figs.  1, 
2C). Earlier studies described KSHV entry as a rapid 
process wherein the capsid delivers the genetic mate-
rial to the nucleus allowing eventual expression of viral 
transcripts in as early as 30 min post infection (PI) [30, 
31]. Here, we monitored KSHV particles in endosomes 
30 min PI. In the case of cells infected with KSHV, there 
was notably more KSHV DNA detected in EE contain-
ing fractions compared to the fractions containing LEs 
(Fig. 2C). Similar results were observed in cells infected 
with a mixture of KSHV and BSA (Fig.  2C). Though 
incubating soluble integrin α9β1 with KSHV did not 
significantly alter the levels of KSHV in EEs, it signifi-
cantly impeded the ability of KSHV to escape the LEs 
(Fig. 2C). These results suggest a possible role for α9β1 
integrin in virus-mediated endosomal escape. Addition-
ally, infection in the presence of our positive control, 
heparin, results in a significant drop in the number of 
virus particles observed in both EE and LE containing 
fractions (Fig.  2C). Notably, pre-treatment of KSHV 
with soluble heparin is shown to impede the initial 
attachment of the virus to HS on the cell surface [32], 
thus blocking binding, signal induction, entry, and effi-
cient infection of target cells [5, 33]. Based on these 
results, as it pertains to HFF cells, we presume KSHV 
to be a late penetrating virus that exits from the LE into 
the cytosol. We could not detect HSV-2 in either the 
early or late endosome (data not shown), as earlier stud-
ies demonstrated HSV-2 to enter target cells via fusion 
at the cell membrane [20].
To further confirm the presence of KSHV in endosome 
containing gradient fractions, fractions collected at dif-
ferent early time points (1, 5, or 30 min) during the course 
of infection were resolved by SDS-PAGE and subse-
quently Western blotted with antibodies directed against 
minor capsid protein KSHV ORF62-encoded triplex 
component I (TRI-1) for detecting the presence of viral 
capsids (Fig. 3). Expression of TRI-1 is ideal for detection 
of the virus, as the virus envelope is lost upon fusion/
penetration. At 1 min post KSHV infection, significantly 
more virus was observed in EE containing fractions 
4–6 versus LE fractions with most virus being detected 
in fraction 5 (Fig.  3). Similar patterns were observed at 
1 min PI when the virus was incubated with BSA or solu-
ble α9β1 (Fig. 3). Incubating KSHV with heparin lowered 
the percentage of virus being internalized as detected by 
limited staining for TRI-1 in EEs (Fig. 3). By 5 min PI, a 
significant portion of the virus had reached LEs in KSHV 
infected cells or cells infected with a mixture of KSHV 
that was incubated with BSA or α9β1 (Fig.  3). Heparin 
blocked KSHV internalization effectively as described at 
Fig. 3 Confirming the presence of KSHV in sucrose gradient fractions at different early time points. Fractions (5 µg protein) collected at different 
early time points (1, 5, or 30 min) during the course of infection were resolved by SDS-PAGE followed by Western blot analysis with anti-KSHV TRI-1 
antibodies
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1 min PI. By 30 min PI, there was a marked drop in the 
levels of virus in LEs (especially LE fraction 1) in cells that 
were infected with KSHV or a mixture of KSHV and BSA 
(Fig. 3). Surprisingly, we found an increase in the levels of 
virus associated with LEs of cells that were infected with 
a mixture of KSHV and soluble α9β1. Overall, Western 
blotting results monitoring TRI-1 expression as an indi-
cator of KSHV in collected gradient fractions of virus 
infected HFF cells (Fig. 3) mimic qPCR results (Fig. 2C), 
thus confirming escape of KSHV from the LE to the cyto-
plasm in HFF cells.
Immunofluorescence microscopy demonstrates KSHV 
to localize in EEs and LEs
For further confirmation, we employed the traditional 
method of immunofluorescence imaging with FITC-
KSHV and TRITC labeled antibodies to Rab5 and Rab7 
to monitor the trafficking of KSHV into the target cells. 
By as early as 1 min PI of cells, KSHV was associated with 
EEs as observed by co-localization of the FITC-KSHV 
with Rab5 expression (Fig.  4a). Treating cells with anti-
bodies to α9β1 or pre-immune IgGs did not significantly 
alter this co-localization (Fig.  4a). At 30  min PI, a frac-
tion of KSHV was associated with LEs as observed by 
co-localization of the FITC-KSHV with Rab7 expres-
sion (Fig.  4b). A similar result was observed when the 
cells were treated with pre-immune IgGs (Fig. 4b). How-
ever, the number of co-localizing events substantially 
increased when the cells were treated with antibodies 
to α9β1 prior to infection (Fig.  4b). For further authen-
tication, subsequent intracellular trafficking of KSHV 
upon cytosolic delivery (post-late endosomal penetra-
tion) was similarly analyzed via immunofluorescence 
microscopy using KSHV and antibodies directed against 
minor capsid protein TRI-1 (Fig. 5). By 30 min PI, KSHV 
was shown to accumulate at the perinuclear region as 
observed by TRI-1 positive viral capsids (similar results 
were observed in cells treated with pre-immune IgGs) 
(Fig. 5A, B). However, when cells were treated with anti-
bodies against integrin subunits (α9 or β1), a substantial 
reduction in perinuclear TRI-1 expression corresponding 
to KSHV nucleocapsids was observed (Fig.  5A, B). This 
reduction in the number of capsids positive for TRI-1 
was not observed when the cells were treated with anti-
bodies to integrin subunit α5 (Fig. 5A, B). Anti-integrin 
α5 antibodies which have no effect on KSHV entry and 
infection [10, 14] served as a negative control (Fig.  5A, 
B). Thus, these results clearly denote the ability of anti-
bodies against integrin subunits (α9 or β1) to block virus 
infection by preventing the escape of KSHV from LEs. 
Overall, we conclude virus:α9β1 interactions to play a key 
role in trafficking of KSHV via endosomes to eventually 
escape into the cytoplasm.
Discussion
Receptors are considered necessary cell surface mol-
ecules instrumental for successful virus infection [34]. 
Herpesvirus entry occurs via viral glycoprotein engage-
ment of target cell receptor molecules. Those recep-
tors considered valuable for KSHV entry into HFF cells 
are binding receptor, HS, RGD-binding integrins (α3β1, 
αVβ3, αVβ5; [5, 7, 14, 35]), and DLD-binding α9β1 inte-
grin [10]. In particular, integrins are known to alter dif-
ferent stages of the virus entry process. Much work has 
been done to establish a role for RGD-binding integrins 
in regulating KSHV infectious entry. Specifically, RGD 
of KSHV gB functionally interacts with integrins α3β1, 
αVβ3, and αVβ5 that have a role in the initial internal-
ization of the virus [5, 7, 14, 35]. However, very little is 
known about the role of DLD-binding integrins during 
the initial stages of KSHV infection. Employing subcellu-
lar fractionation to assess endosomal trafficking of KSHV, 
the present study, for the first time, deciphers a role for 
DLD-binding α9β1 integrin in regulating KSHV entry.
This study utilized a sucrose flotation gradient assay 
to track endocytosed viral cargo through the EEs and 
LEs via subcellular fractionation (Fig. 1). Determining at 
which interface a particular membrane will be detected 
depends on the lipid to protein content ratio. Endosomal 
membranes are considered low density and lipid-rich 
[25]. LEs were expected to be recovered from the inter-
face between 8 and 25 % sucrose, whereas the EEs were 
expected between 25 and 35 % sucrose [36, 37].
In the present report, the PNS derived from KSHV 
infected HFF cells untreated or treated with soluble α9β1 
heparin, or BSA was subjected to high-speed sucrose 
density gradient centrifugation (Fig.  1). Mutually, qPCR 
and Western blotting results revealed significantly lower 
levels of KSHV in LE fractions obtained from KSHV 
infected cells 30  min PI compared to cells that were 
infected with KSHV incubated in the presence of solu-
ble α9β1 (Figs. 2C, 3). In other words, incubating KSHV 
with soluble α9β1 blocked the escape of KSHV from LEs 
to cytoplasm. Taken together, the results from the use of 
subcellular fractionation experiments proved the follow-
ing: (1) DLD-binding integrin α9β1 plays a crucial role in 
the trafficking of KSHV via endosomes; (2) KSHV inter-
nalization into EEs is a rapid event (as little as 1 min PI); 
and (3) KSHV capsids exit LEs to generate a successful 
infection.
This study confirmed the results from the subcellular 
fractionation experiments by also utilizing traditional 
immunofluorescence microscopy (Figs. 4, 5). These find-
ings have taken our current knowledge of KSHV entry 
a step further, delineating yet another dynamic role 
for integrins in a post-internalization stage of KSHV 
infection of HFF cells. Notably, a previous study by 
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A
B
Fig. 4 Antibodies to integrin α9β1 inhibit KSHV escape from the late endosome. A KSHV is present in Rab5-positive EEs and Rab7-postive LEs. HFF 
cells were either uninfected or pre-treated (1 h at 37 °C) with antibodies (20 µg/ml) to α9β1 or pre-immune IgG prior to infection with FITC-KSHV for 
1 min (A) and 30 min (B) at 37 °C. Cells were washed, fixed, and subsequently immunostained with TRITC labeled anti-Rab5 antibodies (A) and TRITC 
labeled anti-Rab7 antibodies (B ) prior to mounting using an anti-fade reagent containing DAPI and examining under a fluorescent microscope. 
Representative images are provided at ×1000 magnification. The white circles indicate co-localization of FITC-KSHV with the respective endosome 
marker within the cell (panels A and B)
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Schornberg et al. also provides evidence that viruses uti-
lize integrins for regulation of virus entry at steps beyond 
binding and initial internalization to promote virus pen-
etration from endocytic organelles. Specifically, they sug-
gest that cell surface integrin expression mediates virus 
entry at this post-internalization step via controlling 
endosomal cathepsins (proteases found in endosomes 
that mediate intracellular proteolysis; [38, 39]). With fur-
ther studies, we seek to resolve: (1) the role for α9β1 in 
mediating proteolytic activity within endosomes; and (2) 
the link between post-internalization virus:integrin inter-
actions and endosomal acidification in supporting a suc-
cessful virus infection of cells.
Conclusions
Subcellular fractionation is a powerful tool to analyze 
the biology of virus entry—especially for those viruses 
that enter via endocytosis. Unlike conventional methods, 
this tool offers better maneuverability for appreciating 
events occurring within individual intracellular orga-
nelles with respect to the internalized virus. The only 
major problem with this approach is that it may seem 
laborious compared to conducting immunofluorescence 
or inhibitor-based infection assays. However, the benefits 
are very many, as subcellular fractionation is a privileged 
technique that can be optimized to analyze: (1) signaling 
events occurring on the surface of endosomes critical to 
the transit of virus particles; (2) events on the endoso-
mal membrane eventually resulting in the escape of the 
capsid; (3) the endosomal milieu critical for the traffick-
ing of the virus; (4) conformational changes on the viral 
envelope and capsid that support successful transit via 
endosomes; and (5) real-time trafficking of the virus par-
ticle through the intracellular components.
Methods
Cells
HFF cells were propagated as per standard laboratory 
protocols [40].
Antibodies
Anti-integrin α9 (H-198) antibodies (Santa Cruz Biotech-
nology); anti-integrin α5 (P1D6), β1 (6S6), α9β1 (Y9A2; 
Millipore) antibodies; Rab5 and Rab7 (D95F2) XP™ 
antibodies (Cell Signaling Technology); purified mouse 
anti-EEA1 (BD Transduction Laboratories) antibody; 
anti-LAMP1 antibody and Anti-Histone H3 antibody 
(Abcam); mouse monoclonal antibody (5B7B6) to KSHV 
orf62 encoded minor capsid protein, TRI-1 (Thermo Sci-
entific) were used in this study.
A
B
Fig. 5 Antibodies against α9 and β1 integrin subunits block KSHV 
nucleocapsid trafficking to the perinuclear region by 30 min PI. A 
HFF cells were untreated or pre-treated (1 h at 37 °C) with antibodies 
(20 µg/ml) to α9, β1, α5 or a pre-immune IgG prior to infection with 
KSHV for 30 min at 37 °C. Cells were washed, fixed, and subse-
quently immunostained for TRI-1 minor capsid protein. Representa-
tive fluorescence imaging depicting TRI-1 positive viral capsids in 
infected HFF cells are shown. Mag ×1000. B Statistical analysis on 
the viral capsids that accumulated around the perinuclear region 
was determined based on randomly counting the number of TRI-1 
positive KSHV capsids around 10 different nuclei. The TRI-1 positive 
viral capsids around the perinuclear region for different treatments 
is presented as percentage (%) as compared to cells infected with 
KSHV alone (n = 60). Data represent the average ±SD (error bars) of 
three experiments. Columns with different alphabets are statistically 
significant (p < 0.05) by LSD
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Proteins and reagents
Recombinant human integrin α9β1 (R and D Systems); 
heparin, and fluorescein isothiocyanate (FITC) (Sigma) 
were used in this study.
Sucrose flotation gradient
Confluent monolayers of adherent HFF cells were cooled 
(4 °C for 30 min) and either remained uninfected (under-
going incubation at 37  °C for 30  min) or were infected 
(undergoing incubation 37  °C for 1, 5, or 30  min) with 
wild type KSHV (MOI of 5 DNA copies/cell) in the pres-
ence of DMEM only or 10 µg/ml α9β1, BSA, or heparin. 
After the designated time point, cells were washed thrice 
with DMEM followed by the application of 0.5  ml of 
homogenization buffer (250 mM sucrose, 1 mM EDTA, 
1  mM phenylmethylsulfonyl fluoride (PMSF)), in which 
cells were gently detached using a cell scraper, lysed, and 
further processed for examination by a sucrose flotation 
assay as previously described [36]. Specifically, after cen-
trifugation (1000×g), the PNS was collected and adjusted 
to a concentration of 25 % sucrose and 1 mM EDTA in 
1  ml total volume. In 1  ml increments, 2.4  ml of 45  % 
sucrose was transferred to the bottom of a SW41Ti tube 
and successively overlaid with 5.2  ml of 35  % sucrose, 
3.9 ml of 25 % sucrose, and 1 ml of PNS in 25 % sucrose. 
Following centrifugation (100,000×g), 2  ml fractions 
were collected from top to bottom, and densities were 
measured by refractometry. These fractions were further 
analyzed using endosomal markers and KSHV. Herpes 
simplex virus-2 (HSV-2) was used as control in this study.
Western blotting and acid phosphatase activity assay
Western blotting was performed as per earlier stud-
ies [30] to monitor expression of Rab 5, EEA1, Rab7, 
LAMP1, and KSHV TRI-1. Acid phosphatase activity 
for lysosome identification was analyzed in 50 µl sample 
from each fraction by using Acid Phosphatase Assay Kit 
(Sigma) according to the manufacturer’s instructions.
Monitoring KSHV levels in gradient fractions by qPCR
KSHV and HSV-2 levels in different fractions collected 
after sucrose flotation gradient centrifugation were deter-
mined by isolating total genomic DNA prior to monitor-
ing orf50 [41] and UL5 gene copies [42], respectively, 
by qPCR [41]. As a benchmark for successful infection, 
orf50 was monitored as per early studies; orf50 is said to 
be expressed within 30 min of successful KSHV infection 
[30].
Immunofluorescence microscopy
 FITC-KSHV and FITC-HSV-2 were generated as per ear-
lier protocols [20]. In order to map the endosomal loca-
tion of KSHV, HFF cells (75  % confluent) cultured in 8 
well chamber slides were either uninfected or infected 
with FITC-KSHV for 1 or 30 min at 37 °C. Post-infection, 
cells were washed in phosphate-buffered saline (PBS) and 
fixed with 3.7  % formaldehyde in PBS for 10  min. After 
fixing, cells were washed, permeabilized using 0.1 % Tri-
ton X-100 in PBS for 3 min, washed again, and incubated 
for 20 min at room temperature with PBS containing 1 % 
bovine serum albumin (BSA) to block non-specific bind-
ing sites. Cells were then incubated successfully (1  h at 
37  °C) with the appropriate primary (anti-Rab5, or anti-
Rab7) and secondary (goat anti-rabbit TRITC) antibod-
ies. Immunostained cells were washed in PBS and imaged 
with a Nikon fluorescent microscope using appropriate 
filters. To study the escape of KSHV from the LEs, we 
infected cells with KSHV for 30  min, fixed the cells as 
described above, and sequentially stained with anti-KSHV 
TRI-1 antibodies and goat anti-mouse TRITC antibodies 
prior to examining under a fluorescent microscope.
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